The Health Resources and Services Administration (HRSA) today unveiled its highly anticipated 340B rebate guidance, proposing a pilot program that [...] …
Category: Regulatory
Three federal appeals judges—who have all ruled on 340B matters in the past—will hear oral arguments in September in a [...] …
A majority of 340B hospitals surveyed said the costs associated with implementing drugmakers’ proposed rebate models would hinder their ability [...] …
A key federal regulator highlighted the Health Resources and Services Administration’s (HRSA) legal fight against proposed drugmaker 340B rebate models [...] …
Three drugmakers are offering refunds to 340B covered entities that purchased certain drugs between 2022 and 2025 following recalculations of [...] …
In a first for the agency, the Centers for Medicare and Medicaid Services (CMS) is proposing to track 340B drugs [...] …
The Trump administration this week proposed accelerating hospital outpatient payment cuts to offset previous 340B hospital lump sum repayments and [...] …
In a flurry of meetings with federal officials, drug industry and provider groups are making a final push to influence [...] …
The U.S. Supreme Court this week greenlit the Trump administration’s plans for massive layoffs and a reorganization at the U.S. [...] …
Kentucky’s Medicaid program this week launched a new 340B claims submission process that enables covered entities to carve in Medicaid [...] …